Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives Average Rating of “Buy” from Analysts
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) have been given a consensus rating of “Buy” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation […]
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) have been given a consensus rating of “Buy” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation […]
